REAL-WORLD COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS EXPOSED TO AT LEAST ONE ANTI-TNF AGENT: LONG-TERM RESULTS FROM THE TORUS STUDY

Anthony Buisson  1     Mélanie Serrero  2     Romain Altwegg  3     Thomas Guilmoteau  1     Guillaume Bouguen  4     Maria Nachury  5     Aurelien Amiot  6     Lucine Vuitton  7     Xavier Treton  8     Ludovic Caillo  9     Bruno Pereira  1     Mathurin Fumery  10    
1 CHU Estaing Clermont-Ferrand, Clermont-Ferrand, France
2 Hopital Nord, Marseille, France
3 Hopital Saint Eloi Hepatologie Gastroenterologie, Montpellier, France
4 CHU Pontchaillou, Rennes, France
5 CHRU Lille, Lille, France
6 Kremlin-Bicetre, APHP Dept. of Gastroenterology, Le Kremlin Bicetre, France
7 Besançon University Hospital Gastroenterology, Besnaçon, France
8 Institut des MICI, Paris, France
9 CHU de Nimes, Nîmes, France
10 Amiens University Hospital, Amiens, France

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing